|Bid||35.04 x 0|
|Ask||35.05 x 0|
|Day's Range||34.89 - 35.24|
|52 Week Range||27.99 - 41.50|
|Beta (5Y Monthly)||0.80|
|PE Ratio (TTM)||11.05|
|Earnings Date||Feb 07, 2023 - Feb 13, 2023|
|Forward Dividend & Yield||1.96 (6.47%)|
|Ex-Dividend Date||Aug 31, 2022|
|1y Target Est||34.11|
Great-West Lifeco Inc. (the "Corporation") announced today that it has received approval from the Toronto Stock Exchange ("TSX") for the renewal of its Normal Course Issuer Bid ("NCIB").
Great-West Lifeco Inc. ("Lifeco") has been notified of an unsolicited mini-tender offer by Obatan LLC, made to residents of Ireland, to purchase up to 50,000 common shares of Lifeco. The unsolicited offer represents a discount of approximately 31.1% to the closing price of the common shares on the TSX on December 29, 2022, the last trading day before the offer was commenced. The common shares do not trade on a recognized stock exchange in Ireland.
Great-West Lifeco Inc. is pleased to announce the appointment of Dervla Tomlin, current Chief Actuary, as Chief Risk Officer, effective February 13, 2023.